In conclusion, these genetic findings highlight the importance of understanding the roles of BRAF, ARID2, KMT2C, and GNAQ in different cancer types, shedding light on potential therapeutic targets and predictive markers for cancer treatment strategies. This evidence concerns the gene ARID2 and cancer.